Four Carlton Fields attorneys — J. Coy Stull, Katherine Teal Leonard, Ahmed-Zayn Mohamed, and Meredith Little — authored an article, “Amgen, Juno and the Fate of Functional Genus Claims,” for Law360. The article discusses the evidence offered and rejected by the Federal Circuit in Juno Therapeutics, Inc. v. Kite Pharma and Amgen v. Sanofi, and by the District Court (by a Federal Circuit Judge presiding) in Baxalta Inc. v. Genentech, Inc. It also discusses the possible ramifications of potential Supreme Court intervention in Amgen v. Sanofi (cert petition pending) and Juno v. Kite (cert petition expected in mid-June).
©2026 Carlton Fields, P.A. Carlton Fields practices law in California through Carlton Fields, LLP. Carlton Fields publications should not be construed as legal advice on any specific facts or circumstances. The contents are intended for general information and educational purposes only, and should not be relied on as if it were advice about a particular fact situation. The distribution of this publication is not intended to create, and receipt of it does not constitute, an attorney-client relationship with Carlton Fields. This publication may not be quoted or referred to in any other publication or proceeding without the prior written consent of the firm, to be given or withheld at our discretion. To request reprint permission for any of our publications, please use our Contact Us form via the link below. The views set forth herein are the personal views of the author and do not necessarily reflect those of the firm. This site may contain hypertext links to information created and maintained by other entities. Carlton Fields does not control or guarantee the accuracy or completeness of this outside information, nor is the inclusion of a link to be intended as an endorsement of those outside sites.
Related People
Shareholder
Media Contact
Senior Public Relations and Communications Manager
